Access to medical products in the South-East Asia Region, 2021

Overview

Member states recognized the need for all countries to have unhindered, timely access to quality, safe, efficacious and affordable diagnostics, therapeutics, medicines and vaccines, and essential health technologies despite challenges faced during COVID-19. Progress has been made in the areas of medicine pricing policies, transparency in decision-making processes, building resilient supply chains, and strengthening of National Medicines Regulatory Authorities (NMRA)s through South-East Asia Regulatory Network (SEARN).